Guselkumab Efficacy in CD Unaffected by Prior Biologic Use

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and biologic-inadequate responders.
Medscape Medical News

source https://www.medscape.com/viewarticle/guselkumab-efficacy-crohns-disease-unaffected-prior-biologic-2024a1000j8n?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost